News dated: January 05, 2011 Xavant Technology (Pty) Ltd announced today that the US Food and Drug Administration (FDA) has granted clearance of the STIMPOD NMS450 nerve stimulator. The STIMPOD NMS450 is the flagship in the STIMPOD range, with applications in both regional and general anesthesia procedures.
News dated: November 29, 2010 Xavant Technology (Pty) Ltd has launched its new website at www.xavant.com. Bold, brilliant and user friendly, the dramatically re-designed website features improved navigation, new digital content and comment sections.
News dated: June 7, 2010 Xavant recently introduced its new range and generation Stimpod NMS410 and NMS450 nerve stimulators in South Africa and international markets. Sales have exceeded all expectations in the first 60 days since its launch on March 25. Xavant began shipping to Europe in May with initial sales expected from France, Germany, Italy, Spain and the UK. The new generation Stimpod will be available in over 40 EU countries in the coming months. The NMS410 is already available in the USA with the NMS450 to follow within the next few months.
News Dated: December 15, 2009 Xavant Technology (Pty) Ltd won a 2009 SABS Design Excellence Award in the medical device category. |
|
|
